My PCR
Create Account
Logo PCR

18 May 2023

TAVI

Redo-TAVI and patient pathway optimisation - Lifetime management decisions today for challenges of the future!

Sponsored by Edwards Lifesciences

Anchorperson: T. Cuisset
Spokesperson: T. Modine
SHOW MORE

Summary

Watch this session if you want to learn more about the BENCHMARK Registry and its key findings, explore how patients can benefit from optimised TAVI programmes, get an idea of how challenging Redo-TAVI will be for everyday practice in the future, and to view a LIVE redo-TAVI case.

Learning Objectives

  • To understand the results of the benchmark registry and how the learnings can be connected to a successful long-term monitoring, increased quality of life and reduced risks for patients
  • To reflect about future challenges after TAVI in patients with longer-life expectancy
  • To be prepared to assess the feasibility of redo-TAVI and to understand what is important in order to find the best treatment strategy
Related Content
Your journey through PCR London Valves 2025 starts here Second valves strategies with SAPIEN 3 Ultra RESILIA Most impactful trials in structural heart disease 2024/2025
Recommended for you
What’s new in the 2025 guidance on valvular heart disease - ESC Congress 2025 ESC Congress 2025: The DOUBLE-CHOICE trial New iterations of self expendable valves - LIVE case